A BILL 
To provide for the issuance of a Lyme Disease Research 
Semipostal Stamp. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. SHORT TITLE. 
3
This Act may be cited as the ‘‘Stamp Out Lyme Dis-
4
ease Act’’. 
5
SEC. 2. FINDINGS AND PURPOSE. 
6
(a) FINDINGS.—Congress finds the following: 
7
(1) The Centers for Disease Control and Pre-
8
vention (CDC) estimate that 476,000 Lyme disease 
9
20:28 Jul 08, 2021
H3491
2 
•HR 3491 IH
cases are diagnosed and treated in the United States 
1
annually. 
2
(2) The CDC reports that Lyme disease is dif-
3
ficult to diagnose due to its diverse manifestations 
4
and a lack of reliable testing options. 
5
(3) The National Institutes of Health (NIH) re-
6
ports that a significant number of later-stage or 
7
post-treatment Lyme disease patients are not cured. 
8
(4) The Tick-Borne Disease Working Group re-
9
ports that 10 to 20 percent of Lyme disease patients 
10
will suffer from persistent symptoms which can be 
11
chronic and disabling. 
12
(5) According to the Johns Hopkins Bloomberg 
13
School of Public Health, Lyme disease costs the 
14
United 
States 
healthcare 
system 
up 
to 
15
$1,300,000,000 per year. 
16
(b) PURPOSE.—To afford a convenient way for mem-
17
bers of the public to contribute to funding for Lyme dis-
18
ease and related tick-borne illness research within the Na-
19
tional Institute of Allergy and Infectious Diseases, the 
20
United States Postal Service shall issue a semipostal 
21
stamp (hereinafter in this Act referred to as the ‘‘Lyme 
22
Disease Research Semipostal Stamp’’) in accordance with 
23
this section. 
24
20:28 Jul 08, 2021
H3491
3 
•HR 3491 IH
SEC. 3. LYME DISEASE RESEARCH SEMIPOSTAL STAMP. 
1
(a) TERMS AND CONDITIONS.—The issuance and sale 
2
of the Lyme Disease Research Semipostal Stamp shall be 
3
governed by the provisions of section 416 of title 39, 
4
United States Code, and regulations issued under such 
5
section. 
6
(b) DISPOSITION OF PROCEEDS.— 
7
(1) IN GENERAL.—All amounts becoming avail-
8
able from the sale of the Lyme Disease Research 
9
Semipostal Stamp (as determined under section 
10
416(d) of such title 39) shall be transferred to the 
11
National Institute of Allergy and Infectious Dis-
12
eases, for the purpose described in subsection (a), 
13
through payments which shall be made at least twice 
14
a year. 
15
(2) PROCEEDS NOT TO BE OFFSET.—In accord-
16
ance with section 416(d)(4) of such title 39, 
17
amounts becoming available from the sale of the 
18
Lyme Disease Research Semipostal Stamp (as so de-
19
termined) shall not be taken into account in any de-
20
cision relating to the level of appropriations or other 
21
Federal funding to be furnished in any year to the 
22
National Institute of Allergy and Infectious Dis-
23
eases. 
24
(c) 
DURATION.—The 
Lyme 
Disease 
Research 
25
Semipostal Stamp shall be made available to the public 
26
20:28 Jul 08, 2021
H3491
4 
•HR 3491 IH
for a period of at least 6 years, beginning no later than 
1
12 months after the date of the enactment of this Act. 
2
(d) DEFINITION.—For purposes of this Act, the term 
3
‘‘semipostal stamp’’ refers to a stamp described in section 
4
416(a)(1) of title 39, United States Code. 
5
Æ 
20:28 Jul 08, 2021
H3491
